Abstract 4096: Assessing individual variability in efficacy and toxicity of autologous and allogeneic chimeric antigen receptor T-cell immunotherapy using a PBMC-humanized mouse model
Won Lee(Gachon University), Jiwon Yang(Burke Medical Research Institute), Heather Gustafson(Seattle Children's Hospital), Katelyn Burleigh(Seattle Children's Hospital), Blair C. Armstrong(Wadsworth Center), Destanie Rose(Jackson Laboratory), Rebecca Gardner(Seattle Children's Hospital), James Keck(Jackson Laboratory)
Cited by 1
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
CD19 CAR T cell product and disease attributes predict leukemia remission durability
|Journal of Clinical Investigation|2019|355
Humanized mice in studying efficacy and mechanisms of PD‐1‐targeted cancer immunotherapy
|The FASEB Journal|2017|352